EFSA | Targeted risk assessment for famoxadone
In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to assess whether existing Codex Maximum Residue Limits (CXLs) for famoxadone are safe for consumers in light of the lowered toxicological reference values established following the non‐renewal of approval of the active substance famoxadone. Based on the targeted assessment EFSA identified a potential acute concern for the CXL on table grapes. For the other CXLs consumers intake concern was not identified.
CONTINUE READING ON www.efsa.europa.eu